China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
About this item
Full title
Author / Creator
Liu, Liping , Wang, Yilong , Xie, Xuewei , Liu, Dacheng , Wang, Aili , Wang, Penglian , Shen, Suwen , Zhong, Chongke , Wei, Yufei , Xu, Tan , Pan, Yuesong , Jiang, Yong , Meng, Xia , Wang, David , Zhang, Yonghong , He, Jiang and Wang, Yongjun
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundsIncreased blood pressure (BP) for patients who had an acute ischaemic stroke is associated with poor functional outcome, however the optimal timing of antihypertensive therapy is unknown.AimsWe aim to compare early antihypertensive treatment to delayed antihypertensive treatment for reducing the risk of composite major disability and mor...
Alternative Titles
Full title
China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2b996214a062463dbac3b3ec91921642
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b996214a062463dbac3b3ec91921642
Other Identifiers
ISSN
2059-8688
E-ISSN
2059-8696
DOI
10.1136/svn-2020-000828
